Anthem, Inc. (ANTM) Shares Sold by Cigna Investments Inc. New
Cigna Investments Inc. New decreased its stake in shares of Anthem, Inc. (NYSE:ANTM) by 5.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,277 shares of the company’s stock after selling 616 shares during the period. Cigna Investments Inc. New’s holdings in Anthem were worth $1,933,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. raised its position in Anthem by 2,873.5% in the first quarter. BlackRock Inc. now owns 22,676,945 shares of the company’s stock valued at $3,750,316,000 after buying an additional 21,914,321 shares during the period. Boston Partners raised its position in Anthem by 112.6% in the first quarter. Boston Partners now owns 3,895,863 shares of the company’s stock valued at $644,298,000 after buying an additional 2,063,562 shares during the period. Wellington Management Group LLP raised its position in Anthem by 53.5% in the first quarter. Wellington Management Group LLP now owns 4,443,160 shares of the company’s stock valued at $734,810,000 after buying an additional 1,548,077 shares during the period. OZ Management LP acquired a new position in Anthem during the first quarter valued at approximately $192,493,000. Finally, FMR LLC raised its position in Anthem by 8.2% in the first quarter. FMR LLC now owns 12,335,115 shares of the company’s stock valued at $2,039,982,000 after buying an additional 934,509 shares during the period. 89.81% of the stock is owned by institutional investors.
Shares of Anthem, Inc. (NYSE ANTM) opened at 191.98 on Wednesday. The company has a market cap of $50.41 billion, a price-to-earnings ratio of 18.15 and a beta of 0.73. Anthem, Inc. has a one year low of $114.85 and a one year high of $194.94. The company’s 50-day moving average is $189.99 and its 200-day moving average is $174.54.
Anthem (NYSE:ANTM) last posted its earnings results on Wednesday, July 26th. The company reported $3.37 EPS for the quarter, beating the Zacks’ consensus estimate of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The company had revenue of $22.20 billion for the quarter, compared to analysts’ expectations of $22.25 billion. During the same quarter in the prior year, the company posted $3.33 earnings per share. Anthem’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, equities analysts predict that Anthem, Inc. will post $11.82 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a $0.70 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.80 dividend on an annualized basis and a yield of 1.46%. This is a boost from Anthem’s previous quarterly dividend of $0.65. Anthem’s dividend payout ratio is presently 24.62%.
TRADEMARK VIOLATION NOTICE: This article was first posted by Daily Political and is the property of of Daily Political. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/08/09/anthem-inc-antm-shares-sold-by-cigna-investments-inc-new.html.
Several equities analysts have commented on ANTM shares. Sanford C. Bernstein increased their price objective on shares of Anthem from $202.00 to $212.00 and gave the company an “outperform” rating in a research report on Friday, April 28th. Deutsche Bank AG increased their price objective on shares of Anthem from $166.00 to $173.00 and gave the company a “hold” rating in a research report on Friday, April 28th. BidaskClub lowered shares of Anthem from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Cantor Fitzgerald reiterated a “hold” rating and set a $165.00 price objective on shares of Anthem in a research report on Monday, April 24th. Finally, Credit Suisse Group started coverage on shares of Anthem in a research report on Wednesday, July 12th. They set a “neutral” rating and a $195.00 price objective for the company. Twelve investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $180.00.
In other news, Director Ramiro G. Peru sold 2,681 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $181.58, for a total transaction of $486,815.98. Following the sale, the director now owns 13,571 shares of the company’s stock, valued at $2,464,222.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Ronald W. Penczek sold 867 shares of the stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $187.46, for a total transaction of $162,527.82. Following the sale, the senior vice president now directly owns 1,872 shares in the company, valued at approximately $350,925.12. The disclosure for this sale can be found here. Insiders sold 4,103 shares of company stock worth $749,555 in the last ninety days. 0.36% of the stock is currently owned by corporate insiders.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.